Publications by authors named "Guillermo de Velasco"

65Publications

Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.

Oncology (Williston Park) 2020 08;34(8):317-319

Department of Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.46883/ONC.2020.3408.0317DOI Listing
August 2020

Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice.

Arch Esp Urol 2020 Jun;73(5):360-366

Sección de Cirugía Oncológica Renal y Trasplante. Servicio de Urología. Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS). Universidad de Alcalá. Madrid. España.

View Article

Download full-text PDF

Source
June 2020

Optimising first-line treatment for metastatic renal cell carcinoma.

Lancet 2020 01;395(10219):e7

Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid 28041, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)32495-XDOI Listing
January 2020

Prognostic and Predictive Value of in Clear Cell Renal Cell Carcinoma.

Cancers (Basel) 2019 Dec 19;12(1). Epub 2019 Dec 19.

Department of Medical Oncology, University Hospital 12 de Octubre, 28041 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12010016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016957PMC
December 2019

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma.

Eur Urol Oncol 2019 09 1;2(5):505-514. Epub 2019 Aug 1.

Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.06.022DOI Listing
September 2019

Update on the management of patients with intermediate and poor-risk testicular germ cell tumors and new biological insights.

Cancer Treat Res Commun 2019 30;19:100117. Epub 2018 Dec 30.

Division of Medical Oncology, 12 de Octubre University Hospital, Avenida de Córdoba s/n 28041 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.100117DOI Listing
September 2019

Challenges of treatment selection in the older prostate patient.

J Geriatr Oncol 2019 07 20;10(4):666-668. Epub 2019 Jan 20.

Medical Oncology Service, University Hospital 12 de Octubre, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.01.009DOI Listing
July 2019

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Eur J Surg Oncol 2018 09 5;44(9):1439-1445. Epub 2018 Jun 5.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.05.026DOI Listing
September 2018

Exosomes: Definition, Role in Tumor Development and Clinical Implications.

Cancer Microenviron 2018 Jun 3;11(1):13-21. Epub 2018 May 3.

Medical Oncology Service, University Hospital 12 de Octubre (Madrid, Spain), Avda Córdoba S/N, 28041, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12307-018-0211-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008261PMC
June 2018

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.

Clin Genitourin Cancer 2018 04 6;16(2):e327-e333. Epub 2017 Dec 6.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.11.005DOI Listing
April 2018

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.

Eur Urol Focus 2019 05 5;5(3):474-481. Epub 2018 Jan 5.

Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2017.12.007DOI Listing
May 2019

In Reply.

Oncologist 2017 12 11;22(12):1561. Epub 2017 Sep 11.

Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728026PMC
December 2017

Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.

Clin Genitourin Cancer 2017 12 2;15(6):e1089-e1094. Epub 2017 Aug 2.

Dana-Farber Cancer Institute, Boston, MA; Hospital De Mar Research Institute-IMIM, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.012DOI Listing
December 2017

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

Cancer Cell 2017 06 18;31(6):820-832.e3. Epub 2017 May 18.

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.04.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502825PMC
June 2017

Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.

Clin Genitourin Cancer 2017 12 21;15(6):652-660.e1. Epub 2017 Mar 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.03.004DOI Listing
December 2017

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.

Eur Urol 2017 08 27;72(2):171-174. Epub 2017 Mar 27.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.03.005DOI Listing
August 2017

Biosimilar biologic drugs: a new frontier in medical care.

Postgrad Med 2017 May 3;129(4):460-470. Epub 2017 Apr 3.

e Global Established Pharma Medicines Development Group , Pfizer Inc , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00325481.2017.1311196DOI Listing
May 2017

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065111PMC
October 2016

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.

J Clin Oncol 2016 09 20;34(27):3267-75. Epub 2016 Jun 20.

Nawar Hanna, Maxine Sun, Christian P. Meyer, Paul L. Nguyen, Steven L. Chang, Guillermo de Velasco, Quoc-Dien Trinh, and Toni K. Choueiri, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA; and Sumanta K. Pal, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024547PMC
September 2016

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.

Cell Rep 2016 Mar 3;14(10):2476-89. Epub 2016 Mar 3.

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.02.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794376PMC
March 2016

Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.

JAMA Oncol 2016 Apr;2(4):500-7

Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2015.4917DOI Listing
April 2016

Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma.

Cancer Immunol Res 2016 Jan 20;4(1):12-7. Epub 2015 Nov 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medical Oncology, Brigham and Women's Hospital, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0197DOI Listing
January 2016

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting.

Urol Oncol 2015 Dec 9;33(12):538-45. Epub 2015 Oct 9.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654640PMC
December 2015

Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment.

Arthritis Rheumatol 2016 Feb;68(2):556-7

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39406DOI Listing
February 2016

Assessing the Contemporary Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Another Step in the Right Direction.

Eur Urol 2016 Jan 6;69(1):92-3. Epub 2015 Jun 6.

Department of Medical Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838150044
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2015.05.040DOI Listing
January 2016